Neglected diseases like TB account for 10.5 percent of the global disease burden, yet between 2000 and 2011, only 3.8 percent of newly-approved drugs were for TB and other neglected infections.
It's World Pneumonia Day November 12. Learn more about the leading cause of death among children worldwide from this UNICEF infographic.
October 17, 2012, Washington, DC – Today the World Health Organization released new data on the global TB epidemic. While the report highlights some welcome successes, it also projects a $2-3 annual gap in funding for TB through 2013. The report also documents a $1.4 billion annual gap in funding for research and development of new drugs, diagnostics and a vaccine.
A new report addressing the current funding crisis at the Global Fund has been released. The report, ‘Bridging the Gap: Why the European Union Must Address The Global Fund’s Funding Crisis to Tackle the Escalating HIV and TB Epidemics in Eastern Europe and Central Asia’, addresses concerns that middle-income countries, particularly those in Eastern Europe and Central Asia (EECA) with a high burden of TB and HIV, will be particularly vulnerable to The Global Fund’s recent reduction in funding.
Last Thursday saw the conclusion of a health fact-finding mission to Zambia, where senior British Parliamentarians called on the Government, international development agencies and civil society members to urgently improve the state of the country’s prisons amid shockingly high rates of TB and HIV.
To bring attention to the need for increased investment in research and development for tuberculosis, ACTION, in partnership with TB Alliance and Aeras, is hosting a free, public session at the 2012 International AIDS Conference, called Saving Lives Through Research & Development: Developing Better Technologies to Address TB/HIV. Global Village’s TB-HIV Networking Zone, Exhibit Hall C, Booth #64, International AIDS Conference, Washington Conference Center, Washington, D.C.